Laboratorios Farmacéuticos ROVI - Top-line growth, significant margin expansion
Laboratorios Farmacéuticos ROVI reported H120 operating revenue of €191.1m (+8% y-o-y), driven by strong growth in heparins (+23% to €104.0m) and...
88 Views
Laboratorios Farmacéuticos ROVI - COVID-19 stockpiling positive impact
Laboratorios Farmacéuticos ROVI (ROVI) reported Q120 operating revenue of €101.0m (+23% y-o-y), driven by strong growth both in the speciality...
33 Views
Laboratorios Farmacéuticos ROVI - Investing for future growth
Laboratorios Farmacéuticos ROVI has reported a strong set of FY19 results, with all pillars of the business contributing to revenue growth of 26%...
627 Views
Laboratorios Farmacéuticos ROVI - Multiple growth drivers lie ahead
Following Laboratorios Farmacéuticos ROVI’s (ROVI’s) recent investor day, we have reviewed our near-term forecasts. Specifically, we upgrade our...
1.5k Views
Laboratorios Farmacéuticos ROVI - Robust growth across key franchises
Laboratorios Farmacéuticos ROVI (ROVI) has reported operating revenue of €270.8m (+24% y-o-y) for the first nine months of FY19 (9M19), driven by...
855 Views